Healthy elementary school student
Conditions
Interventions
Intake of test food for 8 consecutive weeks
Sponsors
Miura Clinic, Medical Corporation Kanonkai
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Healthy elementary school students (1st to 6th grades: excluding menstrual periods) (2) Subjects whose parents or legal guardians (hereinafter referred to as 'guardians') received a full explanation of the purpose and content of the study, fully understood it, and voluntarily provided written informed consent for the subject's participation in the study
Exclusion criteria
Exclusion criteria: (1) Subjects with a history of mental illness, diabetes, liver diseases, renal disease, gastrointestinal disease, cardiac disease, respiratory disease, peripheral vascular disease, or other serious disease. (2) Subjects who have undergone gastrointestinal surgery. (3) Subjects showing abnormal liver and kidney function test values. (4) Subjects with a current medical condition. (excluding cavity treatment) (5) Subjects who are allergic to food and drugs. (6) Subjects who participate in strenuous sports and subjects who are trying to lose weight. (7) Subjects with extremely irregular eating habits. (8) Subjects who cannot stop taking health foods (including foods for specified health use and foods with functional claims) and quasi-drugs during the study period. (9) Subjects who are continuously treated with medications (including OTC, prescription drugs). (10) Subjects who are currently participating in other clinical studies or are scheduled to participate in research at the start of this study. (11) Other subjects judged by the investigator or the investigator to be inappropriate for the examination.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diary | — |
Secondary
| Measure | Time frame |
|---|---|
| Medical examination s-IgA in saliva Height measurement Blood pressure Inbody (weight, muscle mass) Brief-type Diet History Questionnaire for 15-year-old | — |
Countries
Japan
Contacts
Public ContactMakoto Terashima
Oneness Support Co., Ltd. Clinical Trial Division
Outcome results
None listed